Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Absci Corporation - Common Stock
(NQ:
ABSI
)
11.07
+0.32 (+2.98%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Absci Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
September 24, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci to Participate in Upcoming Investor Conferences
September 01, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci (ABSI) Q2 2026 Earnings Call Transcript
↗
August 19, 2026
Biotech extends runway to 2028 with $100M financing and Eli Lilly deal.
Via
The Motley Fool
Topics
Earnings
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
August 19, 2026
News Provided by USA News Group on behalf of MindWalk Holdings Corp.
From
USA News Group
Via
GlobeNewswire
Absci Corp (NASDAQ:ABSI) Plunges on 86% Q1 Revenue Miss Despite Clinical Advances
↗
May 07, 2026
Via
Chartmill
Absci Q2 Earnings Call Highlights
↗
August 11, 2026
Absci (NASDAQ:ABSI) outlined progress in its clinical program for ABS-201, a prolactin receptor-targeting antibody being studied for pattern hair loss and planned for development in endometriosis,...
Via
MarketBeat
Topics
Artificial Intelligence
Earnings
Get insights into the top gainers and losers of Tuesday's after-hours session.
↗
August 11, 2026
Via
Chartmill
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
August 11, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026
July 14, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci Corp. (NASDAQ:ABSI) Reports Mixed Q4 Results Amid Clinical Progress
↗
March 24, 2026
Via
Chartmill
Keep an eye on the top gainers and losers in Wednesday's session.
↗
June 24, 2026
Via
Chartmill
Here are the top movers in Wednesday's session.
↗
June 24, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
June 24, 2026
Via
Chartmill
These stocks that are showing activity before the opening bell on Wednesday.
↗
June 24, 2026
Via
Chartmill
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
June 24, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)
June 24, 2026
From
Absci Corporation
Via
GlobeNewswire
The 1 AI Stock I'd Put in a Time Capsule and Open in 2036
↗
May 25, 2026
A speculative but compelling AI biotech investment can be built around Absci and its attempt to rewire drug discovery itself.
Via
The Motley Fool
Topics
Artificial Intelligence
Absci to Participate in Upcoming Investor Conferences
May 20, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci (ABSI) Q1 2026 Earnings Call Transcript
↗
May 07, 2026
Absci (ABSI) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results
May 07, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 04, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026
April 23, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci (ABSI) Q4 2025 Earnings Call Transcript
↗
March 25, 2026
Absci (ABSI) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
What's going on in today's after hours session
↗
March 24, 2026
Via
Chartmill
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
March 24, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic
March 24, 2026
Experts at the forefront of reproductive medicine, fertility, and translational research will guide the clinical research program for a new therapeutic antibody treatment
From
Absci Corporation
Via
GlobeNewswire
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
March 03, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026
February 24, 2026
From
Absci Corporation
Via
GlobeNewswire
Absci to Participate in Upcoming Investor Conferences
February 17, 2026
From
Absci Corporation
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
